BlackRock Fund Advisors - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 30 filers reported holding CANCER GENETICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2016$51,000
-20.3%
37,660
+2.4%
0.00%
Q3 2016$64,000
-12.3%
36,774
-0.2%
0.00%
Q2 2016$73,000
+12.3%
36,862
+60.6%
0.00%
Q1 2016$65,000
-19.8%
22,957
-6.4%
0.00%
Q4 2015$81,000
-55.0%
24,525
+6.4%
0.00%
Q3 2015$180,000
-13.9%
23,041
+29.4%
0.00%
Q2 2015$209,000
+71.3%
17,805
+13.6%
0.00%
Q1 2015$122,000
+90.6%
15,673
+63.6%
0.00%
Q4 2014$64,000
+68.4%
9,579
+127.9%
0.00%
Q3 2014$38,0004,2030.00%
Other shareholders
CANCER GENETICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Timpani Capital Management LLC 206,579$2,847,0001.42%
Sterneck Capital Management, LLC 95,830$1,321,0000.80%
PERKINS CAPITAL MANAGEMENT INC 81,775$1,127,0000.76%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$1,156,0000.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 354,180$4,881,0000.25%
WHITE PINE CAPITAL LLC 54,350$748,0000.14%
SSI INVESTMENT MANAGEMENT LLC 62,959$868,0000.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 151,214$2,084,0000.08%
ROTHSCHILD INVESTMENT LLC /IL 31,200$430,0000.06%
ARDSLEY ADVISORY PARTNERS LP 27,500$379,0000.05%
View complete list of CANCER GENETICS INC shareholders